| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.04 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.038 | 0.9 |